Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity.
about
Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structuresRegulatory phosphorylation of Ikaros by Bruton's tyrosine kinaseBruton's TK inhibitors: structural insights and evolution of clinical candidates.A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice.Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone diseaseTyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders.The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly.Inhibitors of Bruton's Tyrosine Kinase (Btk) May Treat Inflammation, Immunological Disorders, and Cancer.Development of a pharmacodynamic assay based on PLCγ2 phosphorylation for quantifying spleen tyrosine kinase (SYK)-Bruton's tyrosine kinase (BTK) signaling.Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.
P2860
Q27666787-CB6FA449-D19D-449E-B0BF-F40F3CF4E5CBQ28535431-A9444992-A154-4D7C-ABBD-4A06EA1945E8Q35181271-414B586E-1D2D-4636-BF6D-ADC0C1F5DAA9Q35915693-FACA4CA5-2C09-4616-84AE-3C44A57D3966Q36190423-53B2CC21-7EC7-4420-91C7-11CD0B834742Q37678085-760232B3-529B-4480-815A-611CCEC98010Q38011765-932D9C03-331A-41B2-AE9D-E4B5766E321EQ38106745-66469A09-7140-4CBA-819E-50D6E3D2A0FBQ38544216-3B15329E-E0E9-4A63-AEDC-36A546C2367BQ39779200-D05F2D12-E221-42C1-A38E-922775E2E994Q45982703-9F746468-490B-4601-B879-5A2ABA5D0646Q46134516-253163F2-4415-4E94-8C25-A5EB95C7E34A
P2860
Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bruton's tyrosine kinase as a ...... ry disorders and autoimmunity.
@en
Bruton's tyrosine kinase as a ...... ry disorders and autoimmunity.
@nl
type
label
Bruton's tyrosine kinase as a ...... ry disorders and autoimmunity.
@en
Bruton's tyrosine kinase as a ...... ry disorders and autoimmunity.
@nl
prefLabel
Bruton's tyrosine kinase as a ...... ry disorders and autoimmunity.
@en
Bruton's tyrosine kinase as a ...... ry disorders and autoimmunity.
@nl
P2860
P1476
Bruton's tyrosine kinase as a ...... ry disorders and autoimmunity.
@en
P2093
Sanjive Qazi
P2860
P304
P356
10.1517/13543776.2010.517750
P407
P577
2010-09-10T00:00:00Z